List of bibliographic references indexed by vaccines
Number of relevant bibliographic references: 90.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000103 (2020) |
Shan Lu | Timely development of vaccines against SARS-CoV-2 |
| 000123 (2020) |
Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai Rao | The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000276 (2020) |
Fatima Amanat [États-Unis] ; Florian Krammer [États-Unis] | SARS-CoV-2 Vaccines: Status Report |
| 000481 (2020) |
Eun Kim [États-Unis] ; Geza Erdos [États-Unis] ; Shaohua Huang [États-Unis] ; Thomas W. Kenniston [États-Unis] ; Stephen C. Balmert [États-Unis] ; Cara Donahue Carey [États-Unis] ; V. Stalin Raj [Pays-Bas] ; Michael W. Epperly [États-Unis] ; William B. Klimstra [États-Unis] ; Bart L. Haagmans [Pays-Bas] ; Emrullah Korkmaz [États-Unis] ; Louis D. Falo [États-Unis] ; Andrea Gambotto [États-Unis] | Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development |
| 000567 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000713 (2020) |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000746 (2020) |
Dae-Gyun Ahn [Corée du Sud] ; Hye-Jin Shin [Corée du Sud] ; Mi-Hwa Kim [Corée du Sud] ; Sunhee Lee [Corée du Sud] ; Hae-Soo Kim [Corée du Sud] ; Jinjong Myoung [Corée du Sud] ; Bum-Tae Kim [Corée du Sud] ; Seong-Jun Kim [Corée du Sud] | Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). |
| 000904 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
| 000953 (2020) |
B. Robson | COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance |
| 000C64 (2018) |
Phanramphoei N. Frantz [France, Thaïlande] ; Samaporn Teeravechyan [Thaïlande] ; Frédéric Tangy [France] | Measles-derived vaccines to prevent emerging viral diseases |
| 000C78 (2018) |
Gary Wong [République populaire de Chine] ; Xiangguo Qiu [Canada] | Funding vaccines for emerging infectious diseases. |
| 000D05 (2018) |
Vineet D. Menachery [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Hugh D. Mitchell [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Sarah R. Leist [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Rachel L. Graham [États-Unis] ; Katrina M. Waters [États-Unis] ; Ralph S. Baric [États-Unis] | Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines. |
| 000D43 (2017) |
P Noel Barrett [États-Unis] ; Sara J. Terpening [États-Unis] ; Doris Snow [États-Unis] ; Ronald R. Cobb [États-Unis] ; Otfried Kistner [États-Unis] | Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases. |
| 000D83 (2017) |
Jiwon Choi [Corée du Sud] ; Mi-Gyeong Kim [Corée du Sud] ; Yu-Kyoung Oh [Corée du Sud] ; Young Bong Kim [Corée du Sud] | Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review. |
| 000F82 (2016) |
Stanley Perlman ; Rahul Vijay | Middle East respiratory syndrome vaccines |
| 001402 (2015) |
Rachael S. Felberbaum [États-Unis] | The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors |
| 001576 (2014) |
Yoshikazu Honda-Okubo [Australie] ; Dale Barnard [États-Unis] ; Chun Hao Ong [Australie] ; Bi-Hung Peng [États-Unis] ; Chien-Te Kent Tseng [États-Unis] ; Nikolai Petrovsky [Australie] | Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology |
| 001583 (2014) |
Rachel L. Roper ; Kristina E. Rehm | SARS vaccines: where are we? |
| 001617 (2014) |
Arwen F. Altenburg [Pays-Bas] ; Joost H C M. Kreijtz [Pays-Bas] ; Rory D. De Vries [Pays-Bas] ; Fei Song [Allemagne] ; Robert Fux [Allemagne] ; Guus F. Rimmelzwaan [Pays-Bas] ; Gerd Sutter [Allemagne] ; Asisa Volz [Allemagne] | Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases. |
| 001741 (2014) |
J. Hu [États-Unis] ; C. Zhang [États-Unis] | Porcine Reproductive and Respiratory Syndrome Virus Vaccines: Current Status and Strategies to a Universal Vaccine |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "vaccines"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "vaccines" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= vaccines
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
